Bayer announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Eylea (aflibercept) intravitreal injection 40 mg/mL for the treatment of preterm infants with retinopathy of prematurity (ROP).
- Read more about Bayers Eylea approved in Japan for child ratinopathy
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/bayers-eylea-approved-in-japan-for-child-ratinopathy
No comments:
Post a Comment